Lv1
30 积分 2025-06-07 加入
Genetic and non-genetic drivers of histological progression and regression in MASLD
1个月前
已完结
Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023
1个月前
已完结
Current status and future trends of the global burden of MASLD
1个月前
已完结
Function of orthologous fibroblast growth factor 11 protein in angiogenesis and immunomodulatory after spinal cord injury
4个月前
已关闭
Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway
5个月前
已完结
Mechanistic insights into the liver–brain axis during chronic liver disease
5个月前
已完结
Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States
5个月前
已完结
Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclature
5个月前
已关闭
Function of orthologous fibroblast growth factor 11 protein in angiogenesis and immunomodulatory after spinal cord injury
7个月前
已完结
Function of orthologous fibroblast growth factor 11 protein in angiogenesis and immunomodulatory after spinal cord injury
7个月前
已完结
皖公网安备34019202002308
